Rosiglitazone does not alter the pharmacokinetics of metformin

Journal of Clinical Pharmacology

Volumn 40, Issue 11, 2000, Pages 1280-1285

  Di Cicco, Robert A ^a   Allen, Ann ^a   Carr, Alison ^a   Fowles, Susan ^b   Jorkasky, Diane K ^b   Freed, Martin I ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

^b PENN PRESBYTERIAN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIGUANIDE DERIVATIVE; GLUCOSE; METFORMIN; ORAL ANTIDIABETIC AGENT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; ROSIGLITAZONE;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIABETES MELLITUS; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; DRUG METABOLISM; GLUCOSE BLOOD LEVEL; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL;

ACIDOSIS, LACTIC; ADULT; CROSS-OVER STUDIES; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; HUMANS; HYPOGLYCEMIC AGENTS; MALE; METFORMIN; MIDDLE AGED; THIAZOLES; THIAZOLIDINEDIONES;

EID: 0033735599     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Rosiglitazone (BRL49653) monotherapy has significant glucose lowering effect in type 2 diabetic patients
2. Identification of high-affinity binding sites for the insulin sensitizer rosiglitazone (BRL-49653) in rodent and human adipocytes using a radioiodinated ligand for peroxisomal proliferetor-activated receptor gamma
3. Treatment with the thiazolidinedione (BRL 49653) decreases insulin resistance in obese Zucker hindlimb
4. The influence of food on the pharmacokinetics of BRL 49653C in healthy male volunteers
5. Metformin
6. Prediction of creatinine clearance from serum creatinine
7. LC Phases improve, but not all assays do: Metformin bioanalysis revisited
8. Pharmacokinetics and pharmacodynamics of two oral formulations of metformin hydrochloride
9. Influence of food on the disposition of the antidiabetic drug metformin in diabetic patients at steady-state
10. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ)
11. 2 is a ligand for the adipocyte determination factor PPARγ
12. Disposition of metformin (N,N-dimethylbiguanide) in man
13. Metformin: A new treatment option for non-insulin-dependent diabetes mellitus
14. Metformin
15. Re-evaluation of a biguanide, metformin: Mechanism of action and tolerability